Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

88.45
-2.3200-2.56%
Post-market: 88.450.00000.00%19:30 EDT
Volume:939.42K
Turnover:83.91M
Market Cap:6.09B
PE:-28.38
High:91.37
Open:90.77
Low:88.23
Close:90.77
52wk High:122.20
52wk Low:74.50
Shares:68.85M
Float Shares:65.39M
Volume Ratio:1.14
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1172
EPS(LYR):-3.1100
ROE:-117.04%
ROA:-30.96%
PB:59.14
PE(LYR):-28.44

Loading ...

Mar 20, 2026

Major Issues Report

Form 8-K - Current report
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 09, 2026

Major Issues Report

Form 8-K - Current report
Dec 19, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]